MAP1LC3A and hepatocellular carcinoma: High LC3 expression seems to have a protective effect on clinical outcomes, including HCC recurrence and OS after hepatectomy.7, 8 Our present study demonstrated that low LC3 expression in tumors is correlated with high HCC recurrence and low OS rates.